LNTHLantheus Holdings, Inc.

Nasdaq lantheus.com


$ 123.41 $ -0.20 (-0.16 %)    

Friday, 12-Jul-2024 15:59:55 EDT
QQQ $ 494.79 $ 2.89 (0.59 %)
DIA $ 400.37 $ 2.69 (0.68 %)
SPY $ 559.91 $ 3.51 (0.63 %)
TLT $ 93.88 $ 0.40 (0.43 %)
GLD $ 223.10 $ -0.14 (-0.06 %)
$ 123.42
$ 123.57
$ 0.00 x 0
$ 0.00 x 0
$ 118.45 - $ 123.64
$ 50.20 - $ 124.90
2,412,564
na
8.65B
$ 1.18
$ 18.79
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 07-25-2019 06-30-2019 10-Q
21 04-30-2019 03-31-2019 10-Q
22 02-20-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-26-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-03-2016 03-31-2016 10-Q
34 03-02-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 xpeng--quantumscape-are-among-top-11-mid-cap-stocks-that-performed-well-last-week-july-7-july-13-details

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeut...

 russell-2000-index-notches-strongest-week-of-year-hits-31-month-highs-outlook-is-clouded-by-feds-concerns-over-labor-market-analyst-warns

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-...

 truist-securities-maintains-buy-on-lantheus-holdings-raises-price-target-to-141

Truist Securities analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target ...

 leerink-partners-maintains-outperform-on-lantheus-holdings-raises-price-target-to-127

Leerink Partners maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and raises the price target from $106 to $127.

 new-reimbursement-rules-for-diagnostic-radiopharmaceuticals-is-undoubtedly-positive-for-lantheus-analyst

CMS proposes new Medicare payment rates for 2025, addressing diagnostic radiopharmaceutical costs. The proposed rule includes s...

 lantheus-expands-cancer-pipeline-with-35m-acquisition-of-rm2-rights

Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabli...

 truist-securities-maintains-buy-on-lantheus-holdings-raises-price-target-to-96

Truist Securities analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target ...

 mizuho-maintains-buy-on-lantheus-holdings-raises-price-target-to-100

Mizuho analyst Anthony Petrone maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target from $90 to ...

 lantheus-holdings-q1-adj-169-beats-154-estimate-sales-37000m-beat-34845m-estimate

Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.69 per share which beat the analyst consensus estimate of $1....

 b-riley-securities-maintains-buy-on-lantheus-holdings-raises-price-target-to-99

B. Riley Securities analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target fr...